Last reviewed · How we verify
NCT06248463: WAPA-Pregnan
Blood Pressure Assessment in Waiting Room During Pregnancy
trial testing BP measurement in waiting room for 20 minutes in Hypertension in 659 participants. Not yet recruiting.
31 December 2025
Quick facts
| Lead sponsor | Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 659 |
| Start date | 1 November 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 1 July 2026 |
Drugs / interventions tested
- BP measurement in waiting room for 20 minutes
Conditions studied
- Hypertension — all drugs for Hypertension →
- Pregnancy Induced Hypertension — all drugs for Pregnancy Induced Hypertension →
Sponsor
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
Who can join
Adults 18 to 50, female only, with Hypertension or Pregnancy Induced Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to compare in healthy pregnant women during the first trimester. The main question it aims to answer are: Accuracy of measuring automatically Blood Pressure (BP) at appointment compared to 24 Hour Ambulatory Blood Pressure Monitor (ABPM). Participants will be BP measured with homologated device every 3 minutes in waiting room for 20 minutes. Researchers will compare Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) in clinical visit to see if are comparable to ABPM.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06248463
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura trials
Trials by the same sponsor.
- NCT03239808 — Incremental Haemodialysis in Incident Patients · NA · active not recruiting
- NCT06187532 — Carotid Plaque-Burden Scale and Outcomes. A Real Life Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06248463 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
- Last refreshed: 12 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06248463.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing